- Home
- NOG vs VKTX Comparison
NOG vs VKTX Comparison
Compare NOG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOG | VKTX |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NOG | VKTX |
|---|---|---|
| Price | $22.92 | $29.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 21 |
| Target Price | $30.56 | ★ $95.32 |
| AVG Volume (30 Days) | 1.9M | ★ 4.3M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | ★ 7.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,475,723,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.23 | N/A |
| 52 Week Low | $17.18 | $23.82 |
| 52 Week High | $31.17 | $43.15 |
Technical Indicators
Market Signals| Indicator | NOG | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 54.30 |
| Support Level | $19.67 | $26.47 |
| Resistance Level | $27.53 | $34.00 |
| Average True Range (ATR) | 1.04 | 1.64 |
| MACD | -0.69 | 0.50 |
| Stochastic Oscillator | 13.11 | 93.17 |
Price Performance
Historical ComparisonAbout NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.